SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

  1. Redin, E.
  2. Garmendia, I.
  3. Lozano, T.
  4. Serrano, D.
  5. Senent, Y.
  6. Redrado, M.
  7. Villalba, M.
  8. De Andrea, C.E.
  9. Exposito, F.
  10. Ajona, D.
  11. Ortiz-Espinosa, S.
  12. Remirez, A.
  13. Bertolo, C.
  14. Sainz, C.
  15. Garcia-Pedrero, J.
  16. Pio, R.
  17. Lasarte, J.
  18. Agorreta, J.
  19. Montuenga, L.M.
  20. Calvo, A.
Zeitschrift:
Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426

Datum der Publikation: 2021

Ausgabe: 9

Nummer: 3

Art: Artikel

DOI: 10.1136/JITC-2020-001496 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus